Staten Biotechnology
Nijmegen
About Staten Biotechnology
Staten Biotechnology aims to develop novel and innovative strategies for the treatment of dyslipidemia.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Estimated revenue: $1K – $10K
- Last round: Series Unknown (Jan 2014)
- Website: statenbiotech.com
Industries & Categories
Biotechnology, Therapeutics
Canonical: https://fsome.com/organization/staten-biotechnology-2683225 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.